2026-05-13T19:58:40Z https://api.figshare.com/v2/oai
oai:figshare.com:article/12023025 2020-03-26T16:40:56Z category_27094 portal_549 item_type_3 month_year_03_2020
10.5522/04/12023025.v1 https://figshare.com/articles/dataset/Data_of_craniopharyngioma_management_recurrence_and_endocrine_outcomes/12023025 https://ndownloader.figshare.com/files/22089909 Hussein, Ziad Ziad Hussein Glynn, Nigel Nigel Glynn Martin, Niamh Niamh Martin Alkrekshi, Akram Akram Alkrekshi Mendoza, Nigel Nigel Mendoza Nair, Ramesh Ramesh Nair McCullough, Katherine Katherine McCullough Marcus, Hani J. Hani J. Marcus Dorward, Neil Neil Dorward Grieve, Joan Joan Grieve Fersht, Naomi Naomi Fersht Bouloux, Pierre-Marc Pierre-Marc Bouloux Druce, Maralyn Maralyn Druce Baldeweg, Stephanie Stephanie Baldeweg <![CDATA[Data of craniopharyngioma management, recurrence and endocrine outcomes]]> Health care administration Craniopharyngiomas Endocrinology & Metabolism Hypopituitarism Health Care 2020-03-26 2020-03-26 Dataset 2020 University College London

Craniopharyngiomas are neoplasms of the sellar and parasellar region which develop from the epithelium of the primordial craniopharyngeal canal (Rathke's pouch). Despite their WHO classification as type 1 tumours, craniopharyngiomas are associated with multiple comorbidities including hypopituitarism, obesity and somnolence

In this clinical study, we investigated the management and outcomes of a large cohort of patients with craniopharyngioma, both childhood and adult-onset, from three tertiary endocrine centres in the United Kingdom. The primary aim of this study was to examine temporal trends in the management of craniopharyngioma and their impact on long-term patient’s endocrine function.


]]>